Feature

In the battle to control drug costs, old patent laws get new life


 

KHN’s coverage of prescription drug development, costs, and pricing is supported in part by the Laura and John Arnold Foundation. Kaiser Health News is a nonprofit national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation that is not affiliated with Kaiser Permanente.

Pages

Recommended Reading

New AAP policy statement addresses teen driver risks
MDedge Family Medicine
Proposal to change Part B drug WAC-based reimbursement draws criticism
MDedge Family Medicine
5 things to know about Trump’s new ‘public charge’ immigration proposal
MDedge Family Medicine
House, Senate agree on broad opioid legislation
MDedge Family Medicine
Does America have a gabapentinoid problem?
MDedge Family Medicine
Transgender equality: U.S. physicians must lead the way
MDedge Family Medicine
Mental health visits, boarding continue to climb
MDedge Family Medicine
Physical assaults in the emergency department on the rise, survey finds
MDedge Family Medicine
The patient who doesn’t like you
MDedge Family Medicine
Employer health insurance: Deductibles rising faster than wages
MDedge Family Medicine